Henry Schein elects William Daniel as independent chairman

Henry Schein Inc. (NASDAQ: HSIC) announced that its board of directors has elected William K. "Dan" Daniel as independent chairman of the board, effective May 21, 2026. Daniel succeeds Stanley M. Bergman, who retired from the board following 44 years as a director and was named chairman emeritus.

Daniel joined the Henry Schein board of directors in May 2025. He previously served for 14 years as executive vice president at Danaher Corporation (NYSE: DHR), where he oversaw multiple business segments including Danaher's dental portfolio. Daniel also served as a board director at Envista Holdings Corporation (NYSE: NVST) when it was spun off from Danaher.

"I am deeply honored to assume the role of Chairman and am committed to building upon the extraordinary foundation that Stan Bergman and Team Schein established over his tenure," Daniel said in a statement.

Bergman said he has worked with Daniel for many years and has respect for his business acumen and leadership. Fred Lowery, chief executive officer of Henry Schein, expressed gratitude for Bergman's contributions over more than four decades and welcomed Daniel as chairman.

Henry Schein describes itself as a provider of health care solutions to office-based dental and medical practitioners. The company has more than 25,000 employees worldwide and serves more than 1 million customers globally. Henry Schein reported sales of $13.2 billion in 2025 and is headquartered in Melville, New York, with operations in 34 countries and territories.

You May Also Be Interested In

• QXO faces stockholder lawsuit ahead of TopBuild merger vote
• Seer and Korea University share early cancer screening proteomics data
• Organon closes license deal for copper IUD Miudella with Sebela